Clicky

 

Intelligence » Cellulitis » Last Week

Subscribe to get latest posts via email or subscribe to a RSS feed.

[Articles] Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial

Thursday, December 14, 2017 -- Adjunctive rifampicin provided no overall benefit over standard antibiotic therapy in adults with S aureus bacteraemia.

[Comment] Rifampicin for Staphylococcus aureus bacteraemia: give it ARREST

Thursday, December 14, 2017 -- Although Staphylococcus aureus bacteraemia is both common and potentially lethal, clinical decisions involving its treatment remain largely unencumbered by high-quality data.1 With the ARREST multicentre, randomised, double-blind, placebo-controlled trial, Guy Thwaites and colleagues2 have contributed high-quality evidence and addressed an unresolved question involving the role of adjunctive rifampicin in treatment regimens for patients with S aureus bacteraemia.